Literature DB >> 9283238

Glucocorticosteroids as immunosuppressive agents.

L A Cohn1.   

Abstract

When administered at pharmacological dosages, glucocorticosteroid hormones alter leukocyte kinetics, phagocytic cell function, cell-mediated immunity, and, to a lesser extent, humoral immunity. These properties are used to advantage in the treatment of immunologically mediated disease. Corticosteroids are used to suppress pathological immune responses associated with autoimmunity, inhibit rejection of allogenic tissues after organ transplantation, and to diminish inflammation associated with a wide variety of hypersensitivity disorders. The mechanisms by which corticosteroids relieve these conditions are still not completely understood but have recently become more comprehensible. By understanding how corticosteroids exert their effects, we can make better clinical decisions in the management of immune-mediated disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9283238     DOI: 10.1016/s1096-2867(97)80026-6

Source DB:  PubMed          Journal:  Semin Vet Med Surg (Small Anim)        ISSN: 0882-0511


  4 in total

1.  Characteristics of adverse effects when using high dose short term steroid regimen.

Authors:  Kyung Hyun Min; Chung-Ku Rhee; Jae Yun Jung; Myung-Whan Suh
Journal:  Korean J Audiol       Date:  2012-09-20

2.  Influence of dexamethasone on some cellular aspects of the immune system in cats.

Authors:  M Hoffmann-Jagielska; A Winnicka; D Jagielski; R Lechowski
Journal:  Vet Res Commun       Date:  2003-12       Impact factor: 2.459

Review 3.  Cushing's disease: the burden of illness.

Authors:  Rosario Pivonello; Maria Cristina De Martino; Monica De Leo; Chiara Simeoli; Annamaria Colao
Journal:  Endocrine       Date:  2016-05-17       Impact factor: 3.633

4.  Epidemiological evaluation of cat health at a first-response animal shelter in Fukushima, following the Great East Japan Earthquakes of 2011.

Authors:  Aki Tanaka; Philip H Kass; Beatriz Martinez-Lopez; Shinichi Hayama
Journal:  PLoS One       Date:  2017-03-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.